[1]
Vityala Yethindra, Ainura Dzhangazieva, Zhyldyz Kurzhunbaeva, Tugolbai Tagaev and Furquan Nazami 2020. VYTR hypothesis for the prophylactic and therapeutic efficacy of GS-5734 treatment in humans with COVID-19. International Journal of Research in Pharmaceutical Sciences. 11, SPL1 (Apr. 2020), 19-22. DOI:https://doi.org/10.26452/ijrps.v11iSPL1.2007.